These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20351351)

  • 21. The early diagnosis of Parkinson's disease.
    Brooks DJ
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S10-8. PubMed ID: 9749569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders.
    Wallert ED; van de Giessen E; Knol RJJ; Beudel M; de Bie RMA; Booij J
    J Nucl Med; 2022 Jun; 63(Suppl 1):27S-32S. PubMed ID: 35649651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Functional imaging: role for the diagnosis and therapeutic evaluation of Parkinson's disease].
    Remy P
    Rev Neurol (Paris); 2010 Oct; 166(10):770-4. PubMed ID: 20832091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease.
    Brooks DJ
    J Neurol; 2000 Apr; 247 Suppl 2():II11-8. PubMed ID: 10991656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic dysfunction in PD: a window to early detection?
    Goldstein DS; Sewell L; Sharabi Y
    J Neurol Sci; 2011 Nov; 310(1-2):118-22. PubMed ID: 21529844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging non-dopaminergic function in Parkinson's disease.
    Brooks DJ
    Mol Imaging Biol; 2007; 9(4):217-22. PubMed ID: 17340229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine: PET Imaging and Parkinson Disease.
    Peng S; Doudet DJ; Dhawan V; Ma Y
    PET Clin; 2013 Oct; 8(4):469-85. PubMed ID: 27156474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chemical tools for imaging dopamine release.
    Post MR; Sulzer D
    Cell Chem Biol; 2021 Jun; 28(6):748-764. PubMed ID: 33894160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Imaging of Extrapyramidal Movement Disorders.
    Frey KA
    Semin Nucl Med; 2017 Jan; 47(1):18-30. PubMed ID: 27987553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Not Available].
    Azulay JP; Tranchant C
    Presse Med; 2017 Mar; 46(2 Pt 1):174. PubMed ID: 28325375
    [No Abstract]   [Full Text] [Related]  

  • 31. Dopamine Metabolite Biomarkers and Testing for Disease Modification in Parkinson Disease.
    LeWitt PA
    JAMA Neurol; 2020 Aug; 77(8):1038-1039. PubMed ID: 32597929
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopamine Metabolite Biomarkers and Testing for Disease Modification in Parkinson Disease-Reply.
    Moussa C
    JAMA Neurol; 2020 Aug; 77(8):1039-1040. PubMed ID: 32597985
    [No Abstract]   [Full Text] [Related]  

  • 33. Imaging in Parkinson's disease.
    Pagano G; Niccolini F; Politis M
    Clin Med (Lond); 2016 Aug; 16(4):371-5. PubMed ID: 27481384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical therapist practice and the role of diagnostic imaging.
    Boyles RE; Gorman I; Pinto D; Ross MD
    J Orthop Sports Phys Ther; 2011 Nov; 41(11):829-37. PubMed ID: 22048788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in imaging in Parkinson's disease.
    Stoessl AJ; Martin WW; McKeown MJ; Sossi V
    Lancet Neurol; 2011 Nov; 10(11):987-1001. PubMed ID: 22014434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease: diagnosis.
    Brooks DJ
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S31-3. PubMed ID: 22166447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging in Parkinson disease: from research setting to clinical practice.
    Politis M
    Nat Rev Neurol; 2014 Dec; 10(12):708-22. PubMed ID: 25385334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resting state functional magnetic resonance imaging in Parkinson's disease.
    Prodoehl J; Burciu RG; Vaillancourt DE
    Curr Neurol Neurosci Rep; 2014 Jun; 14(6):448. PubMed ID: 24744021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.
    Schwarz ST; Afzal M; Morgan PS; Bajaj N; Gowland PA; Auer DP
    PLoS One; 2014; 9(4):e93814. PubMed ID: 24710392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.